
Sinisa Dovat MD
Professor, Pediatrics, Pennsylvania State University College of Medicine
Join to view full profile
500 University DrHershey, PA 17033
Phone+1 800-243-1455
Fax+1 608-263-0440
Dr. Dovat is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Pediatric Hematology/Oncology, 1996 - 1999
Penn State Milton S Hershey Medical CenterResidency, Pediatrics, 1993 - 1996
University of Novi Sad Faculty of MedicineClass of 1988
Certifications & Licensure
CA State Medical License 1996 - Present
PA State Medical License 1994 - 2026
WI State Medical License 2004 - 2021
American Board of Pediatrics Pediatric Hematology-Oncology
Publications & Presentations
PubMed
- Pharmacological blockade of rho kinase enhances venetoclax responses in translational models of acute myeloid leukemia.Upendarrao Golla, Riya Bhalodia, Charyguly Annageldiyev, Satyam Patel, Vishnu Sravan Bollu
Haematologica. 2026-10-01 - Establishment of Patient-Derived Organoids for Pediatric Cancer Research.Muhammad Younis, Tarlan Arjmandi, Mohammad Haque, Katherine McClain, Thussenthan Walter-Angelo
Cancers. 2026-05-02 - Lineage-specific CK2α deletion reshapes the transcriptome of hematopoietic stem cells toward an immune-primed state.Hannah Valensi, Rajesh Rajaiah, Marudhu Shanmugam, Daniyal Muhammad, Upendar Golla
Biorxiv. 2026-04-15
Abstracts/Posters
- CK2 Inhibitor CX4945 Shows Strong In Vivo Synergistic Anti-Leukemia Activity with Rapamycin in B-ALL Due to Enhanced Ikaros Mediated Repression of mTOR PathwaySinisa Dovat, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- CK2 Inhibitor CX4945 Shows Strong In Vivo Anti Leukemia Effect in AML Via Augmented Ikaros-Mediated Regulation of Global Epigenetic LandscapeSinisa Dovat, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Oncogenesis of CRLF2 Overexpression and Effect of JAK2 Inhibitor in CRLF2 Overexpressed B-Cell Acute Lymphoblastic LeukemiaSinisa Dovat, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Press Mentions
College of Medicine Awarded $4 Million Grant to Advance Pediatric Oncology ResearchSeptember 25th, 2024
College of Medicine Awarded $4 Million Grant to Advance Pediatric Oncology ResearchSeptember 25th, 2024- Increased Incidence of IKZF1 Deletions and IGH-CRLF2 Translocations in B-ALL of Hispanic/Latino Children—a Novel Health DisparityFebruary 2nd, 2021
Grant Support
- Novel targeted therapy to reduce health disparities in pediatric leukemiaPENNSYLVANIA STATE UNIV HERSHEY MED CTR2023–2028
- The Role Of Zinc Finger Genes In LeukemogenesisNational Heart, Lung, And Blood Institute2010–2011
- The Role Of Zinc Finger Genes In LeukemogenesisNational Heart, Lung, And Blood Institute2009–2010
- The Role Of Zinc Finger Genes In Cellular ProliferationNational Cancer Institute2005–2007
- The Role Of Zinc Finger Genes In HematopoiesisNational Cancer Institute2003
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: